Use of the Product. 4.1. As of the Effective Date of this Agreement, Axway grants to Customer, subject to the terms and conditions of this Agreement, a non-exclusive, non-assignable and non-transferable right to Use the Licensed Component for Customer’s own internal business purposes only. Any delay in any payment of the fees related to this Agreement as set forth in Article 8 thirty (30) days beyond the payment date will automatically suspend the right to Use the Licensed Component for Customer, upon written notice by Axway. The Product, including portions and information or materials thereof, may not be used for any purpose that would be a violation of this Agreement. All rights not addressed herein are specifically reserved by Axway. Customer shall not Use the Product to provide services to third parties, including ASP, facilities management, outsourcing, unless expressly provided for in an Order Form.
Use of the Product. 4.1. The Client shall only use any Product in accordance with the safety regulations, the operating instructions and other specifications of TriLite. Any other use of the Product is expressly prohibited. If damage arises from use contrary to the Agreement, the Client shall indemnify and shall hold TriLite harmless in this regard.
Use of the Product. DigiFlak will supply the User with the Product. You may use the Product on as many devices as you want. The Software of the Product is provided on an “as is” and "as available" basis without warranty, express or implied, of any kind or nature, including, but not limited to, any warranties of performance or merchantability or fitness for a particular purpose.
Use of the Product. 7.1 Subject to certain limitations described in this section and elsewhere in this Purchase Agreement, the MSRB grants to Purchaser a limited non-exclusive, non- transferable (except as allowed herein), non-sublicensable, license: (i) to make the Product available to designated employees for their own internal research and business use in the normal course of their employment; and (ii) to use and re-disseminate the Product, subject to the limitations described in this Purchase Agreement. Purchaser may re-disseminate the Product or portions thereof to Purchaser’s end user clients for their internal business purposes, including limited redistribution by Purchaser’s end user clients. End user client shall mean any professional entity that utilizes the Product in the normal course of its business, which includes, the right of limited re-distribution of such information to their clients; provided however, the term does not include those users who re-distribute the Product or any portion thereof for a fee (other than customary printing, copying and similar charges) except as part of a derivative product produced by such end user client that would not reasonably be expected to serve as a substitute for the Product so as to bypass any applicable MSRB licensing or related fees. Purchaser is expressly prohibited from re-disseminating the Product or any portion thereof to commercial vendors or other entities that are in the business of re-disseminating data or information for re-dissemination other than as set forth in the immediately preceding sentence. Except as stated above, no permission is granted for Purchaser to re-disseminate the Product, or any portion thereof, to any party for the purpose of further re-dissemination. Purchaser agrees to inform such clients of this restriction and to take commercially reasonable steps to prevent such clients from re-disseminating the Product, or any portion thereof, in violation of this paragraph as soon as Purchaser is informed or otherwise becomes aware that such unauthorized re-dissemination is occurring. Purchaser may use the Product to create derivative work, which shall be owned by Purchaser; provided, however, that Purchaser shall have no ownership rights to the Product, or any portion thereof, and may not use such derivative work to evade the restrictions on re-dissemination described in this paragraph.
Use of the Product. 184.108.40.206 SFJ will (i) in conducting the Clinical Trials, only use Product supplied by PB or such Third Parties designated by PB; (ii) only use the Product supplied by PB or Third Parties designated by PB, and require that its Permitted Third Parties that receive any of the Product supplied by PB or Third Parties designated by PB only use such Product, for the sole purpose of conducting the Clinical Trials in accordance with the respective Protocols; and (iii) ensure subject dosing compliance per the respective Protocols for the Clinical Trials conducted in the European Clinical Trial Countries or the SFJ Territory. Dosage and Administration Instructions will be provided to SFJ by PB sufficiently in advance of the Clinical Trials’ commencement.